Literature DB >> 8696248

Validity of the SCID in substance abuse patients.

H R Kranzler1, R M Kadden, T F Babor, H Tennen, B J Rounsaville.   

Abstract

Structured or semi-structured interviews, including the Structured Clinical Interview for DSM-III-R (SCID), are used widely to maximize the reliability and validity of psychiatric diagnoses. Although the reliability of such interviews appears adequate, there has been little effort to evaluate their validity. In a sample of 100 substance abuse patients, we evaluated the concurrent, discriminant and predictive validity of SCID substance use diagnoses, as well as co-morbid disorders that occur commonly among these patients. The validity of current and life-time substance use diagnoses obtained by a research technician using the SCID was good; it was moderate for antisocial personality disorder and major depression and poor for anxiety disorders. Although accurate diagnosis of substance use disorders in substance abuse patients can be accomplished by a research technician, the diagnosis of co-morbid psychiatric disorders requires either additional expertise or the use of a diagnostic instrument specially designed for that purpose.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8696248

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  58 in total

1.  The National Survey on Drug Use and Health Mental Health Surveillance Study: calibration study design and field procedures.

Authors:  Lisa J Colpe; Peggy R Barker; Rhonda S Karg; Kathy R Batts; Katherine B Morton; Joseph C Gfroerer; Stephanie J Stolzenberg; David B Cunningham; Michael B First; Jeremy Aldworth
Journal:  Int J Methods Psychiatr Res       Date:  2010-06       Impact factor: 4.035

2.  The Effectiveness and Cost of Clinical Supervision for Motivational Interviewing: A Randomized Controlled Trial.

Authors:  Steve Martino; Manuel Paris; Luis Añez; Charla Nich; Monica Canning-Ball; Karen Hunkele; Todd A Olmstead; Kathleen M Carroll
Journal:  J Subst Abuse Treat       Date:  2016-05-08

3.  Posttraumatic stress disorder symptoms and risky behaviors among trauma-exposed inpatients with substance dependence: The influence of negative and positive urgency.

Authors:  Nicole H Weiss; Matthew T Tull; Tami P Sullivan; Katherine L Dixon-Gordon; Kim L Gratz
Journal:  Drug Alcohol Depend       Date:  2015-08-02       Impact factor: 4.492

4.  The impact of depression on abstinence self-efficacy and substance use outcomes among emerging adults in residential treatment.

Authors:  Brenna L Greenfield; Kamilla L Venner; John F Kelly; Valerie Slaymaker; Angela D Bryan
Journal:  Psychol Addict Behav       Date:  2012-01-30

5.  A perfect platform: combining contingency management with medications for drug abuse.

Authors:  Kathleen M Carroll; Bruce J Rounsaville
Journal:  Am J Drug Alcohol Abuse       Date:  2007       Impact factor: 3.829

6.  Measuring depression at the end of life: is the Hamilton Depression Rating Scale a valid instrument?

Authors:  Megan Olden; Barry Rosenfeld; Hayley Pessin; William Breitbart
Journal:  Assessment       Date:  2008-08-01

Review 7.  Psychopathology in bariatric surgery candidates: a review of studies using structured diagnostic interviews.

Authors:  Sarah Malik; James E Mitchell; Scott Engel; Ross Crosby; Steve Wonderlich
Journal:  Compr Psychiatry       Date:  2013-10-24       Impact factor: 3.735

8.  Which mental disorders are associated with the greatest impairment in functioning?

Authors:  Mark J Edlund; Jiantong Wang; Kristen Gulledge Brown; Valerie L Forman-Hoffman; Sara L Calvin; Sarra L Hedden; Jonaki Bose
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2018-06-29       Impact factor: 4.328

9.  Reward-sensitivity, inhibition of reward-seeking, and dorsolateral prefrontal working memory function in problem gamblers not in treatment.

Authors:  Victor Leiserson; Robert O Pihl
Journal:  J Gambl Stud       Date:  2007-06-15

Review 10.  Prospective: Is bipolar disorder being overdiagnosed?

Authors:  Tammas Kelly
Journal:  Int J Methods Psychiatr Res       Date:  2018-06-14       Impact factor: 4.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.